Navigation Links
Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
Date:9/17/2012

GM-CSF gene, to enhance the immune response against cancer cells.

Hepatocellular Carcinoma: A Global Unmet Need
Hepatocellular carcinoma is the fifth most common cancer worldwide and the third leading cause of cancer death, with over 600,000 new cases diagnosed annually resulting in more than 90 percent mortality.  The annual incidence rate in the U.S., Europe, Japan and China are estimated to be 20,000, 55,000, 40,000 and 350,000 patients, respectively. The only treatment approved for HCC is sorafenib. There is no treatment approved for patients who fail sorafenib.

About Jennerex's Partners for JX-594
Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, holds an exclusive license to develop and commercialize JX-594 in Europe and neighboring countries. Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, holds an exclusive license to develop and commercialize JX-594 in South Korea, and Lee's Pharmaceutical Ltd. holds an exclusive license to develop and commercialize JX-594 in China.

Transgene, a member of the Institut Merieux Group, is a publicly traded French biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases, and has five compounds in clinical development: TG4010 and JX-594 (TG6006) having completed initial phase II trials, TG4001 in phase IIb trial, TG4040 in phase II trial and TG4023 in phase I trial. Transgene has concluded strategic agreements for the development of two of its immunotherapy products, an option agreement with Novartis for the development of TG4010 to treat various cancers, and an in-licensing agreement with U.S.-based Jennerex Biotherapeutics, Inc., to develop and market JX-594 (TG6006), an oncolytic product. Transgene has bio-manufacturi
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
2. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
3. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
4. Mettler Toledo Presents In-depth Guidance to Comply with New USP Chapters 41 and 1251 on Balances Used for Quantitative Analysis in the Pharma QC Lab
5. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
6. Informex Global Pharma Sourcing 2012 Presents Key Strategies & Insight For Business Success
7. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
8. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
9. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
10. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
11. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  Air Products (NYSE: ... supply of medical oxygen is vital to any healthcare ... innovations that not only improve the efficiency of its ... Products will highlight these systems—including systems for emergency ... oxygen loss—from August 4-5 at the 51 st ...
(Date:7/28/2014)... 2014 Southern Research Institute today announced ... and CEO of Southern Research Institute, has been ... for the 2014-2015 term.  The inauguration took place ... in Chicago with attendees ... The Controlled Release Society is an international, interdisciplinary, ...
(Date:7/28/2014)... July 28, 2014  A prospective study conducted ... has validated the performance of VolparaDensity ... has associated volumetrically assessed breast density measurements to ... Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, ... for widespread breast cancer risk assessment," was authored ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4
... , MADISON, N.J., Nov. ... the world,s leading provider of diagnostic testing, information and services, ... Annual Piper Jaffray Healthcare Conference in New York City. ... 9:30 a.m. Eastern Time. , During the conference, the company ...
... , POTOMAC, Md., Nov. 24 ... Diane Wisneski has added Philadelphia jurors to her Thanksgiving gratitude ... just choice. I am so thankful to them," she said ... Pharmaceuticals. , Wisneski is among 12,000 women nationwide who ...
Cached Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 The Eleventh ... Venture Summit concluded with the $10,000 prize being presented ... ( http://www.bikanta.com ) , The 11th Annual Summit was ... with entrepreneurs who can bring innovative products and services ... are pleased to have had such excellent array of ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Lean and Lovely, ... choice for women who want to wear a bikini in ... Stan Stevenson, prompting an investigative review. , “Our Lean ... designed for women at all fitness levels. Neither your age ... how unfit your body is at the beginning, you will ...
(Date:7/29/2014)... July 29, 2014 Consilium Staffing, Your Partner ... at the halfway point of 2014, with strong indications the ... second half of this year. , “This is a great ... President of Consilium Staffing. , “We are proud of ... year, but we are even more excited about how things ...
(Date:7/29/2014)... 29, 2014 The Multiple System Atrophy ... announced the appointment of five new members to its ... announced the election of its executive directors. The ... members and 2 Physician Advisors. These 12 dedicated ... mission of education, support, advocacy and research funding for ...
(Date:7/29/2014)... 2014 Launched in 2012 by veteran ... 20,000 hangovers earlier this year at its Vegas location. ... and the publication of research data related to the ... , The only licensed medical practice dedicated to the ... in 2012 and treated thousands of patients within the ...
Breaking Medicine News(10 mins):Health News:Silicon Valley Boomer Venture Summit Names Bikanta Competition Winner 2Health News:Lean and Lovely: Review Examining Neghar Fonooni’s Program Released 2Health News:Consilium Staffing Experiences Significant Revenue Growth 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:Hangover Heaven Surpasses 20,000 Hangovers 2Health News:Hangover Heaven Surpasses 20,000 Hangovers 3
... another look at that attractive magazine their daughter is ... who read articles on weight loss and dieting in ... weight reducing techniques such as vomiting, laxatives or smoking ... published in Pediatrics' January edition, was conducted by studying ...
... the US the present guidelines should be modified affirms ... Respiratory and// Critical Care Medicine. This will need all ... have originally come from high risk areas around the ... ,Data on all 2004 TB cases listed ...
... or methicillin-resistant Staphylococcus aureus, or CA-MRSA was thought to ... are anything to go by, the bug appears to ... has resulted in an upsurge of infection in the ... ,Lately infections have been on the ...
... British doctor of Indian origin and his colleague are set ... challenge to the monopoly of multinational drug companies. ,Sunil ... Steve Brocchini from the London School of Pharmacy are leading ... ,The two academics have devised a way to ...
... post-traumatic stress disorder show reduced pain sensitivity, a pattern ... the brain, according to a report. ,Post-traumatic stress ... in individuals exposed to a traumatic event. It is ... avoidance of stimuli related to the event, according to ...
... levels of symptoms of Post-Traumatic Stress Disorder (PSTD) may ... same age without the disorder, a new study says. ... potentially debilitating condition that can occur in people who ... a natural disaster or a serious accident. ...
Cached Medicine News:Health News:Drop That Glossy, Girl! 2Health News:TB can Be Eradicated in the U.S With Modified Guidelines: Study 2Health News:NRI Doctor's R&D Model in India to Slash Cost of Drugs 2Health News:Patients With PTSD Experience Less Pain Sensitivity 2
... Knee System is designed to provide the ... of clinical indications. Based on the clinically ... 1984, P.F.C. SIGMA continues a history of ... designed to address implant longevity by maximizing ...
The Biopro Modular TKO implant is among the thinnest bone conserving Posterior Cruciate Ligament sparing knees available. It provides all the benefits of the Biopro TKO implant and gives the option o...
... allows for full interchangeability between femoral ... offers a one-piece molded tibial component ... component as well as modular capability.,The ... in total knee replacement when primary ...
Tibial distractor...
Medicine Products: